In vitro identification and characterization of an early complex linking HIV-1 genomic RNA recognition and Pr55Gag multimerization

J Biol Chem. 2004 Sep 17;279(38):39886-94. doi: 10.1074/jbc.M405632200. Epub 2004 Jul 9.

Abstract

The minimal protein requirements that drive virus-like particle formation of human immunodeficiency virus type 1 (HIV-1) have been established. The C-terminal domain of capsid (CTD-CA) and nucleocapsid (NC) are the most important domains in a so-called minimal Gag protein (mGag). The CTD is essential for Gag oligomerization. NC is known to bind and encapsidate HIV-1 genomic RNA. The spacer peptide, SP1, located between CA and NC is important for the multimerization process, viral maturation and recognition of HIV-1 genomic RNA by NC. In this study, we show that NC in the context of an mGag protein binds HIV-1 genomic RNA with almost 10-fold higher affinity. The protein region encompassing the 11th alpha-helix of CA and the proposed alpha-helix in the CA/SP1 boundary region play important roles in this increased binding capacity. Furthermore, sequences downstream from stem loop 4 of the HIV-1 genomic RNA are also important for this RNA-protein interaction. In gel shift assays using purified mGag and a model RNA spanning the region from +223 to +506 of HIV-1 genomic RNA, we have identified an early complex (EC) formation between 2 proteins and 1 RNA molecule. This EC was not present in experiments performed with a mutant mGag protein, which contains a CTD dimerization mutation (M318A). These data suggest that the dimerization interface of the CTD plays an important role in EC formation, and, as a consequence, in RNA-protein association and multimerization. We propose a model for the RNA-protein interaction, based on previous results and those presented in this study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dimerization
  • Gene Products, gag / chemistry
  • Gene Products, gag / genetics*
  • Gene Products, gag / metabolism*
  • Genome, Viral
  • HIV-1 / genetics*
  • In Vitro Techniques
  • Nucleocapsid Proteins / genetics
  • Protein Binding
  • Protein Precursors / chemistry
  • Protein Precursors / genetics*
  • Protein Precursors / metabolism*
  • Protein Structure, Tertiary
  • RNA, Viral / metabolism*

Substances

  • Gene Products, gag
  • Nucleocapsid Proteins
  • Protein Precursors
  • RNA, Viral
  • p55 gag precursor protein, Human immunodeficiency virus 1